Mirai
Mammography-based model predicting five-year breast cancer risk from the four standard screening views, designed to be robust across hospitals and to work with or without clinical risk factors.
At a glance
What it does
Outputs risk at years 1–5 from a screening mammogram; the paper compares it with the Tyrer-Cuzick model and reports higher discrimination on internal and external cohorts.
Tasks, data types and cancers
Architecture
Training data
Screening mammograms from Massachusetts General Hospital with cancer follow-up; external validation at Karolinska (Sweden) and Chang Gung Memorial Hospital (Taiwan).
Evaluation
| Benchmark / dataset | Metric | Value | External validation | Source |
|---|---|---|---|---|
| MGH test / Karolinska / CGMH | C-index (5-year risk) | higher than Tyrer-Cuzick v8 in all three (paper) | yes | Source |
How to run
Weights and inference code on GitHub; requires DICOM preprocessing described in the repo.
Regulatory status and intended use
Regulatory status is quoted from the source linked above and can change. Research-use-only models must not be used for clinical decisions.
Limitations and bias
- Vendor-specific mammography systems in training; calibration must be checked per site.
- Risk model, not a lesion detector.
Sources
This page is educational — it is not medical advice and does not replace consultation with an oncologist. Diagnostic and treatment decisions are made solely by specialist physicians.